Search results for “Kallikrein Inhibitors” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 366 patents, we discovered top 26 key players by total patent application. KalVista Pharmaceuticals Ltd., BioCryst Pharmaceuticals, Inc., Takeda Pharmaceutical Co., Ltd. are dominant in this area. They take 58.47% of the total patent filing.
KalVista Pharmaceuticals Ltd.
United Kingdom
Patent: 104
BioCryst Pharmaceuticals, Inc.
Alabama, United States
Patent: 64
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 46
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 43
Dyax Corp.
Massachusetts, United States
Patent: 25
Rezolute, Inc.
Colorado, United States
Patent: 18
ActiveSite Pharmaceuticals, Inc.
California, United States
Patent: 17
Merck Sharp & Dohme LLC
New Jersey, United States
Patent: 9
Novartis AG
Basel-Stadt, Switzerland
Patent: 8
Shire Human Genetic Therapies, Inc.
Massachusetts, United States
Patent: 7
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 1 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Attune Pharmaceuticals, Inc.
New York, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 186 patents applied in the last 5 years. We discover 16 most active companies in this area. The fast-growing KalVista Pharmaceuticals Ltd., Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Co., Ltd. take 54.30% of patent filing during this period.
KalVista Pharmaceuticals Ltd.
United Kingdom
Patent: 36
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 35
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 30
BioCryst Pharmaceuticals, Inc.
Alabama, United States
Patent: 29
Rezolute, Inc.
Colorado, United States
Patent: 18
ActiveSite Pharmaceuticals, Inc.
California, United States
Patent: 17
Dyax Corp.
Massachusetts, United States
Patent: 9
Merck Sharp & Dohme LLC
New Jersey, United States
Patent: 9
Shire Human Genetic Therapies, Inc.
Massachusetts, United States
Patent: 7
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 4
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 186 patents in last 5 years, we discover 10 new entrants. Rezolute, Inc., ActiveSite Pharmaceuticals, Inc., Merck Sharp & Dohme LLC are the most active new entrants in this area.
Rezolute, Inc.
Colorado, United States
Patent: 18
ActiveSite Pharmaceuticals, Inc.
California, United States
Patent: 17
Merck Sharp & Dohme LLC
New Jersey, United States
Patent: 9
Shire Human Genetic Therapies, Inc.
Massachusetts, United States
Patent: 7
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 4
Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Sichuan Sheng, China
Patent: 3
Merck Sharp & Dohme BV
Noord-Brabant, Netherlands
Patent: 2
Oxurion NV
Vlaams-Brabant, Belgium
Patent: 1
Clearside Biomedical, Inc.
Georgia, United States
Patent: 1
Katholieke Universiteit Leuven
Vlaams-Brabant, Belgium
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 2 patents, we discovered top 2 universities and scientific research institutions by total patent application.
Katholieke Universiteit Leuven
Vlaams-Brabant, Belgium
Patent: 1
University of Zurich
ZURICH, Switzerland
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: